scholarly journals Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

The Prostate ◽  
2009 ◽  
Vol 69 (12) ◽  
pp. 1303-1311 ◽  
Author(s):  
Jeannette M. Schenk ◽  
Alan R. Kristal ◽  
Marian L. Neuhouser ◽  
Catherine M. Tangen ◽  
Emily White ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hyperplasia ◽  
Cancer Prevention ◽  
Prostatic Hyperplasia ◽  
Prevention Trial ◽  
Serum Adiponectin ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
C Peptide ◽  
Prostate Cancer Prevention ◽  
Prostate Cancer Prevention Trial

scholarly journals Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial

2011 ◽  
Vol 173 (12) ◽  
pp. 1419-1428 ◽  
Author(s):  
J. M. Schenk ◽  
A. R. Kristal ◽  
K. B. Arnold ◽  
C. M. Tangen ◽  
M. L. Neuhouser ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hyperplasia ◽  
Cancer Prevention ◽  
Prostatic Hyperplasia ◽  
Prevention Trial ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
Prostate Cancer Prevention ◽  
Prostate Cancer Prevention Trial

scholarly journals Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

The Prostate ◽  
2009 ◽  
Vol 70 (6) ◽  
pp. 584-590 ◽  
Author(s):  
Alan R. Kristal ◽  
Douglas K. Price ◽  
Cathee Till ◽  
Jeannette M. Schenk ◽  
Marian L. Neuhouser ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Benign Prostatic Hyperplasia ◽  
Cancer Prevention ◽  
Prostatic Hyperplasia ◽  
Repeat Length ◽  
Cag Repeat ◽  
Prevention Trial ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
Prostate Cancer Prevention
Sign in / Sign up

Export Citation Format

Share Document